Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Vasogen autocellular response therapy appears effective in RA

Nov. 29, 1996

Partners sought for 3DP MHC blockers

Nov. 29, 1996

Disappointing results reported for genital herpes vaccine

Nov. 28, 1996

Vaccine against H. influenzae offered for licensing

Nov. 26, 1996

NABI to reformulate StaphVAX

Nov. 26, 1996

GBS vaccine proven safe and immunogenic

Nov. 25, 1996

New macrocyclic immunosuppressants from Abbott

Nov. 20, 1996

Astra claims orally active peptide immunomodulators

Nov. 19, 1996

Novo Nordisk claims immunosuppressive serine palmitoyl transferase inhibitors

Nov. 19, 1996

Italian introduction for CellCept

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...